Regal Rexnord Corporation (NYSE: RRX) — A Deleveraging Roll-Up Re-Rated to Its Richest-Ever Price, Still Earning Below Its Cost of Capital

⚡ Claude’s Take

This block is the author’s own independent opinion and general information only — not investment advice and not a recommendation to buy or sell any security. The analysis that follows (sections 1–15) is presented as position-free, evidence-first research; only this block takes a view.

Verdict: HOLD / AVOID buying here / accumulate-on-weakness / NOT a short. Conviction: Medium. Rough fair-value zone ~$150–$175 (≈11–12x EV/EBITDA, ≈14–16x forward adjusted EPS); I would start accumulating sub-$150 and would not chase above the low-$200s.

Regal Rexnord is the rare roll-up where the operating story has genuinely turned good — top-quartile gross margins, ~$1.6B of debt repaid in two years, cross-sell synergies hit a year early, and a real secular pivot in Automation & Motion Control (data-center power, aerospace & defense, medical, discrete automation). The trouble is the price. After a ~+51% trailing year and a near-double off the April-2025 low, the stock sits at its richest-ever own-history valuation (composite 97th percentile of its own multi-year range, P/S 99th), at ~20.7x my estimate of forward adjusted EPS and ~14.4x EV/adjusted-EBITDA — while the underlying business still earns a ~4.6% return on invested capital, comfortably below its ~8–9% cost of capital. The equity has worked on financial repair (deleveraging + multiple re-rating + a cyclical earnings recovery off a 2023 trough), not yet on economic value creation: the $5.1B Altra deal actually pushed ROIC down, and it has stayed pinned in the 4–5% range. You are being asked to pay a full multiple for a turnaround that is real but incomplete, on the eve of a brand-new CEO (ex-Schneider Aamir Paul, in the chair ~July 1, 2026), with the single sexiest growth vector — data-center ePOD assembly — sitting in the lowest-moat pocket of the whole portfolio, exactly where Marathon-style capital-cycle mean-reversion bites first.

The framing is a cyclical/automation re-rating, not a quality-compounder — and that matters because the factor tape agrees: RRX is a high-beta (~1.5) Industrials/Automation cyclical with a poor long-run Sharpe (~0.25) and a >50% historical drawdown, enjoying a sharp recent surge, not a low-vol compounder. It is cheap versus peers on EV/EBITDA precisely because its returns and balance sheet are the weakest in the cohort — the discount is earned, not a free lunch. It is also not a short: the industrial cycle is inflecting up, deleveraging is structurally bullish for the equity, and momentum is intact. The honest call is HOLD — a good business at the wrong entry price. What flips me bullish: two clean quarters showing consolidated ROIC climbing toward 7–8% as synergies + cycle + AMC mix lift returns toward the cost of capital, plus the data-center backlog converting to the ~$900M 2027 revenue management guides. What flips me bearish: the industrial recovery stalling (organic back to flat), the data-center ePOD vector mean-reverting on competitive capacity, or a leverage-funded re-acquisition spree under the new CEO that re-breaks the balance sheet. Tag: the roll-up finally worked — and the market paid full freight the moment it did.

📈 Stock Price Action — Five-Year Event Map

Over the trailing ~60 months RRX has round-tripped and then broken out. The stock fell to a five-year low of ~$93 (8 April 2025) and ran to an all-time high of ~$231 (6 May 2026), currently ~$220 (26 June 2026) — a 52-week range of roughly $128 → $231 that leaves it ~5% below its record high. The defining feature is the violence and recency of the move: from a December-2025 base near $140 the stock has nearly doubled, including a single ~+25% two-session gap on the Q4-2025 print in early February 2026. This is now a stock near its record high, not a recovery name — and the entire advance is ~14 months old, not a long-running compound. (Fact: five-year price history; drivers below are Interpretation.)

Cycle narrative. The Rexnord PMC combination and 2021 reflation lifted RRX into year-end 2021 (1); the 2022 rate shock de-rated it and priced an industrial downturn (2); a 2022→early-2023 bounce carried it back toward $153 (3). The ~$5B debt-funded Altra acquisition (closed March 2023), a FY2023 GAAP net loss, and the destocking margin trough drove a multi-month drawdown (4). Visible deleveraging and the WEG motors divestiture reset sentiment into a +50%+ recovery (5) — which then fully reversed over March-2024→April-2025 as short-cycle demand stayed weak, bottoming at ~$93 (6). From that trough a powerful re-rate began on a cyclical bottoming plus the data-center / AMC growth narrative (7); the Q4-2025 print triggered the single largest move, ~+25% on 5–8x volume (8); and the Pinkham→Paul succession coincided with the run to the $231 all-time high and a consolidation back to ~$220 (9). The price move in every row is a Fact from the CSV; the attributed cause is Interpretation cross-referenced to the 8-K calendar and earnings dates.

1. Executive Summary

Regal Rexnord is a ~$5.9B-revenue diversified industrial — electric motors, mechanical power-transmission components (bearings, couplings, gearing, clutches/brakes), and automation/motion products — assembled through two transformational deals: the November-2021 Reverse Morris Trust combination with Rexnord’s Process & Motion Control business (~$4.0B) and the March-2023 cash acquisition of Altra Industrial Motion (~$5.1B). It subsequently sharpened the portfolio by selling its commodity Industrial Motors & Generators business to WEG in 2024. The company reports three segments: Industrial Powertrain Solutions (IPS, ~44% of sales, the profit center), Automation & Motion Control (AMC, ~28%, the secular-growth engine), and Power Efficiency Solutions (PES, ~28%, the cyclical HVAC-motor laggard).

The investment debate is unusually clean. On the bull side: the integration is working. Gross margin has reached “top-quartile versus relevant industrial peers” (management), cross-sell synergies hit their $250M target a year early, the Altra cost-synergy program is tracking, net debt has fallen from ~$5.8B (2023) to ~$4.3B (2025), and AMC is riding genuine secular tailwinds — data-center power distribution (revenue guided from $120M in 2025 toward ~$900M in 2027 as the ePOD program ramps), aerospace & defense (orders +76% in Q1-2026), medical, and discrete automation. After a multi-year destocking trough, the core industrial cycle is inflecting: Q1-2026 orders rose +8.5% daily and backlog +6.7% sequentially.

On the bear side: the deals destroyed, or at best have not yet created, economic value. Reported ROIC is ~4.6% — below an ~8–9% WACC — and it fell after the Altra deal, with ~$10.0B of goodwill and intangibles now sitting on a balance sheet whose tangible equity is deeply negative. Organic growth has been anemic (revenue declined from $6.25B in 2023 to $5.93B in 2025; Q1-2026 organic was only +1.6% with residential HVAC still down ~20%). The gap between $4.20 GAAP diluted EPS and ~$9.6 adjusted is almost entirely ~$346M/year of acquired-intangible amortization that will recur into the late 2030s. Reported FY2025 free cash flow of ~$893M is overstated by ~$370M of a one-time accounts-receivable securitization; sustainable FCF is closer to ~$520M. Insiders have made zero open-market purchases in two years, and the 2023 relative-TSR PSUs paid 0% (17th percentile). A brand-new CEO takes over July 1, 2026.

The tension the rest of this memo resolves: RRX is simultaneously cheap versus its cohort (~14.4x EV/adjusted-EBITDA, the lowest among diversified-industrial peers) and at its own richest-ever multiple (97th percentile) after a +51% year. The cross-sectional discount is earned — RRX has the lowest ROIC and highest leverage in the group — so the bull case rests not on closing the peer gap but on whether continued deleveraging, a cyclical recovery, and AMC mix-shift can finally lift consolidated returns over the cost of capital. As of mid-2026 that has not happened, and the price already embeds a good deal of optimism that it will.

2. Business Overview

Regal Rexnord (the former Regal Beloit, renamed in 2021 after the Rexnord PMC combination; headquartered in Milwaukee, Wisconsin; ~30,000 employees) designs and manufactures electromechanical and mechanical motion products. The business model is classic diversified-industrial: sell engineered components and sub-systems to OEMs that embed them into capital equipment, then capture a higher-margin aftermarket/replacement stream over the installed life of that equipment, sold through both direct and distributor channels. Roughly 97% of the legacy components book is replacement-driven over a full cycle, which is the source of the recurring-revenue claim — though, as Section 4 argues, the company does not disclose the aftermarket split that would let an outsider verify the franchise economics.

Segment structure (FY2025, from the 10-K):

¹ GAAP segment operating margin is depressed by heavy acquired-intangible amortization (especially in IPS and AMC from the Altra deal); the adjusted EBITDA margins management discusses on calls are materially higher. (Fact: FY2025 10-K Note 5; Q1-2026 earnings call, 7 May 2026.)

• IPS is the bearings/couplings/gearing/clutch-and-brake powertrain business — the Rexnord PMC + Altra core. End-markets: general industrial, metals & mining, energy, food & beverage, commercial HVAC. It is the largest and most profitable segment (~25% adjusted EBITDA margin) and the home of the “industrial powertrain” cross-sell and aftermarket thesis.
• AMC is the secular-growth engine: conveying systems and conveyor automation (Arrowhead, System Plast), aerospace components, precision/miniature motion control, controls/drives/linear actuators, automatic transfer switches/switchgear, and the modular ePOD data-center power-distribution units. End-markets: discrete factory automation, aerospace & defense, medical, food & beverage, and data center. Margins are currently below the rest of the company (rare-earth supply constraints, tariff timing, and OEM-heavy mix) but management targets a mid-20s adjusted EBITDA margin.
• PES is fractional-to-~5HP AC/DC motors, variable-speed controls, fans/blowers, and air-moving subsystems for residential and commercial HVAC. It is the most cyclical and commodity-exposed segment; residential HVAC volumes fell ~20% in Q1-2026, though margins held up on favorable mix.

Geographic mix: ~70% of revenue is North America, ~17% Europe, ~7.5% Asia, ~5.5% rest of world. Operationally the footprint is far more global — roughly two-thirds of employees and most plants are outside the US (Mexico, China, India), which is central to the tariff discussion in Section 8. (Fact: FY2025 10-K Note 5, employee disclosures.)

How the company got here — the roll-up timeline. Understanding RRX requires understanding that today’s company barely resembles the Regal Beloit of 2019. The transformation ran in four moves: (1) November 2021 — the Reverse Morris Trust combination with Zurn’s Rexnord Process & Motion Control business (~$4.0B), which roughly doubled the company and made power-transmission components a core, and the bolt-on of Arrowhead Systems ($316M) in food-and-beverage conveying; (2) October 2022 → March 2023 — the announcement and close of the all-cash, debt-funded Altra Industrial Motion acquisition (~$5.1B), adding clutches, brakes, and factory-automation motion and taking the company to ~$6.3B of revenue at the cost of a balance sheet levered to 5.7x; (3) April 2024 — the divestiture of the low-margin commodity Industrial Motors & Generators business to WEG ($444M), shrinking revenue but lifting the portfolio’s average margin and “quality”; and (4) the ongoing 2023–present integration-and-deleveraging phase. The renaming, the headquarters move to Milwaukee, and the segment realignment (to today’s IPS/AMC/PES) all flow from these deals. The investment consequence is that almost no line of the financials has a clean five-year organic comparison — every trend is contaminated by deal timing — which is precisely why the GAAP-vs-adjusted and ROIC questions in Sections 6–7 matter so much.

The economic engine. Strip away the complexity and RRX is a high-mix, low-capex components manufacturer: thousands of SKUs of motors, bearings, couplings, gears, and motion sub-systems, sold roughly half to OEMs (lower margin, but they build the installed base) and half through distribution and aftermarket (higher margin, recurring). Management quantifies the flywheel as “an OEM install drives ~6x its revenue in aftermarket over 20 years at 10–20 points higher margin” — the same agency/aftermarket dynamic that underpins the best power-transmission and aerospace franchises. If true at scale, it is a real source of durable, high-return revenue; the open question (Section 4) is that RRX does not disclose the data to prove the flywheel is actually turning at the consolidated level.

Verdict: A coherent, well-organized portfolio of motion and power-transmission franchises with a genuine secular-growth pocket (AMC) bolted onto a cyclical commodity-motor business (PES) and an attractive but capital-intensive-to-build core (IPS). The model generates strong cash conversion because capex is low (~1.6% of sales). The recurring-revenue/aftermarket story is plausible but, at the consolidated level, unproven in the returns.

3. Industry Dynamics

RRX straddles four distinct profit pools, and they are not equally attractive.

(a) Electric motors and power-transmission components (~55–60% of RRX; IPS + most of PES). The global electric-motor market is ~$120–140B and PT components ~$100B+, both growing low-single-digit (GDP-plus) through the cycle. The pool is bifurcated. Commodity fractional/integral-HP motors (residential HVAC, the PES book) are a structurally poor, fragmented, price-competitive, China-exposed segment with low barriers — contestable by Nidec, WEG, Broad-Ocean, and Asian OEMs. Power-transmission components (the Rexnord/Altra book in IPS — bearings, couplings, mechanical PT, clutches/brakes) are structurally better: still fragmented, but spec-in, MRO/aftermarket-heavy, and distributor-served, with real switching costs at the maintenance level. On the Marathon capital-cycle lens, general industrial PT/motors is emerging from a multi-year destocking trough (2023–2025) — distributors over-ordered post-COVID, then drained inventory through 2024–25, and orders are now inflecting positive with no capacity overbuild and disciplined capex. That is a favorable mid-cycle entry point on the supply side.

(b) Data-center electrical power distribution (the AMC growth vector). This is the same AI-capex prize that Eaton, Vertiv, nVent, Schneider, ABB, and Legrand are all chasing — power distribution near the rack (ePODs/power pods, busway, switchgear-adjacent). Demand is growing 20%+. But white-space data-center power is among the least-defended parts of the electrical industry — a land-grab that every major player is funding simultaneously. The RRX-specific problem is sharper still: its ePOD offering is a systems-assembly / integration business with low internal vertical integration — it buys breakers, busbar, and monitoring and assembles them — which is the lowest-moat slice of an already low-moat pocket, pursued as a sub-scale latecomer against incumbents who own the switchgear, the busway, and the spec relationships. Hot demand, structurally weak position; this is the part of the story most exposed to capital-cycle mean-reversion as capacity catches up.

© Factory / discrete automation (AMC). Global discrete/industrial automation is ~$200B growing mid-single-digit. The durable profit pools — Allen-Bradley/Logix installed base; process DCS — are owned by Rockwell (NA discrete) and Emerson/Siemens (process), earning 20–35% margins behind deep switching costs. RRX is not a controls/PLC player; its “automation” is the component layer beneath the automation moat — conveying, motion, sensors, actuation. Good industry, wrong tier. The humanoid-robot actuation “optionality” is real R&D but speculative and unsized (Q1-2026 humanoid orders were ~$1M, down from ~$40M a year earlier) — not investable today.

(d) Residential / commercial HVAC motors (PES). RRX’s structurally worst pool: tied to US housing and repair-replace, with a regulatory tailwind from efficiency-standard-driven ECM-motor conversion, but fierce competition (Nidec/Genteq, Broad-Ocean, Asian imports) and low differentiation. Commodity, cyclical, China-exposed.

Two opposing capital cycles inside one company (Marathon lens). The framework’s central insight — that high returns and growth attract capital, build capacity, and compete away excess returns — applies in opposite directions to RRX’s two halves. The general-industrial PT/motors core is in the constructive phase: a multi-year destocking shakeout has rationalized inventory and held capex disciplined, with no rush of new entrants, so depressed returns are positioned to recover as volume returns — a classic Marathon recovery setup. The data-center power vector is in the dangerous phase: every major player (Eaton, Vertiv, nVent, Schneider, ABB, Legrand) is funding white-space capacity simultaneously into a 20%+ growth pocket, and Marathon’s warning is that the excess returns get competed away first in the lowest-barrier sub-segments — exactly where RRX’s low-vertical-integration ePOD assembly sits, as a sub-scale latecomer adding its own capacity into the flood. A third, RRX-specific capital-cycle signal is favorable and often overlooked: the company is contracting its balance sheet (deleveraging from 5.7x to 3.6x), and the asset-growth anomaly works in reverse — debt paydown and asset discipline are historically associated with positive forward excess returns. Net: the supply side of the core is supportive and the balance-sheet trajectory is supportive; the risk is concentrated in the one pocket the market is most excited about.

Verdict: mixed-to-average. The blend is one structurally-average-but-cyclically-recovering pool, one structurally-good-but-wrong-tier pool, one hot-but-least-defended pool, and one structurally-poor commodity pool. The supply side of RRX’s core (general industrial) is supportive; the risk is the market paying up for the DC vector that is most exposed to capital-cycle mean-reversion.

4. Competitive Position

RRX’s central marketing claim is “unrivaled scale and scope” plus cross-sell and installed-base aftermarket pull. Greenwald’s test is unforgiving: a moat must show up as returns that would deteriorate without it. At the consolidated level, RRX’s numbers do not corroborate a wide moat — ROIC ~4.6%, ROE ~13%, operating margin ~11.5% sit at or below Greenwald’s no-moat benchmark and are the lowest in the entire diversified-industrial cohort (PH ~17% ROIC / ~26% ROE; AME ~12% all-in but ~29% ex-goodwill; ETN ~15%). The scale/scope/cross-sell story is, consolidated, largely unproven in returns. The moats are real but pocketed:

• IPS (bearings/couplings/gearing) — the best moat, narrow. Type: customer captivity (spec-in + MRO search costs) plus modest distribution density. PT components are specified into equipment, embedded for the asset’s life, and replaced through distributors at higher margin — a genuine narrow moat. But it is sub-scale versus the pure-plays: SKF, Timken, and RBC Bearings are deeper, more spec’d-in, higher-return bearings franchises (Timken runs ~18–20% EBITDA margins on a focused engineered-bearings moat; RBC earns 30%+ gross on premium aerospace-bearings spec-in). RRX’s PT book is broader but shallower per niche.

• AMC — bifurcated (a barbell). The aerospace/defense, medical, and precision-motion slice carries a real spec-in/certification switching-cost moat — the highest-quality part of RRX, directly analogous to the aerospace annuity in AME/PH, but far smaller and less established. The headline data-center ePOD business has little-to-no durable moat — a low-vertical-integration assembly operation competing on capacity, lead-time, and price against Eaton/Vertiv/nVent. That is a cyclical, not structural, advantage; in Marathon’s framing, lead-time “moats” evaporate when capacity catches up.

• PES — weakest/largely absent. Commodity motors, Nidec/Broad-Ocean/Asian competition, low switching costs, brand largely irrelevant. A scale-cost operator in a contestable market — Greenwald’s worst position (stuck between the low-cost scale leader and the premium-engineering leader).

The cross-sell / aftermarket-pull claim (“an OEM install drives ~6x its revenue in aftermarket over 20 years at 10–20 points higher margin”) is directionally credible as an aspiration and consistent with how PT/aerospace aftermarkets work. Management reports cross-sell reaching its $250M target a year early — a real, encouraging data point. But it is unproven in the consolidated returns: there is no aftermarket-revenue disclosure validating the 6x multiplier, and a ~5% ROIC argues the aftermarket pull is not yet flowing through to franchise-grade returns. Treat it as a management hypothesis, not evidence.

Verdict: A portfolio of mostly-narrow, pocketed moats (IPS PT components; AMC aerospace/medical motion) bolted to a no-moat commodity-motor business (PES) and a low-moat DC-assembly growth vector. There is no single hard-to-replicate moat asset, and the consolidated returns prove it. The advantage, where it exists, is real but does not justify a compounder valuation. RRX’s closest analog is a more-levered, lower-quality, more-cyclical Parker-Hannifin — “good position out of mediocre markets” — without PH’s distribution moat, aerospace-annuity depth, or capital-allocation record.

5. Growth History and Forward Opportunities

History is dominated by M&A, not organic growth. Revenue went from $2.9B (2020) to $3.8B (2021, Rexnord PMC mid-year) to $5.2B (2022) to a $6.25B peak (2023, full-year Altra) — and then declined to $6.03B (2024, after the WEG divestiture) and $5.93B (2025). Strip the deals and the divestiture and the underlying organic record over 2023–2025 is poor: revenue per share fell from $94.3 to $89.5, and FY2025 organic growth was just +0.8%. This was a destocking-depressed period across general industrial and a deep residential-HVAC downturn, so it is partly cyclical — but it is not the record of a secular grower, and it is the backdrop against which the stock has nonetheless doubled.

The forward case is an inflection, and the early evidence is encouraging. In Q1-2026, daily orders rose +8.5% and backlog +6.7% sequentially; April orders were +4.6%. The standouts are in AMC: total AMC orders +34% (aerospace/defense +76%, medical +53%, discrete automation +18%; +28% even excluding data center), with a 1.24 book-to-bill. IPS short-cycle OEM orders were up high-single-digits and distribution up low-single-digits — the earliest signs of a US industrial cycle recovery, corroborated by expansionary ISM readings — while PES showed “tentative signs that residential HVAC markets are finding a floor.” Management raised 2026 organic growth assumptions across all three segments and now guides ~4.5% total revenue growth with adjusted EPS of $10.20–$11.00 (midpoint ~10% growth).

The marquee opportunity is data center. Management sizes RRX data-center revenue at $120M (2025) → $180M (2026, switchgear, no ePOD) → ~$900M (2027), the jump driven by the ePOD power-distribution ramp (~$700M of ePOD plus ~$240M switchgear in 2027), supported by a $735M ePOD order and new Texas and Canada capacity coming online by mid-2026. This is genuine and large — but it is lumpy, project-based, and concentrated, the ePOD backlog largely ships through 2027 with 2028 demand not yet ordered, and (per Section 4) it sits in the lowest-moat pocket of the portfolio. It is the single largest swing factor in both the bull thesis and the multiple.

To size what the data-center ramp is actually worth: a jump from $120M (2025) to ~$900M (2027) is ~$780M of incremental revenue. At management’s stated ~20%+ ePOD adjusted EBITDA margin, that is on the order of ~$160M of incremental EBITDA by 2027 — meaningful against ~$1.3B of company EBITDA (~12%), but a) two years out, b) front-loaded into 2027 with a visible 2028 air-pocket unless new orders land by year-end 2026 (management’s own framing), and c) earned in an assembly business that, by management’s admission, will dilute AMC’s margin mix in the near term even as it adds dollars. The honest way to hold the data-center story is as real, large, but low-quality and time-limited growth — a reason the stock can keep working into 2027 if orders convert, and a reason the multiple is fragile if the 2028 funnel disappoints. Beyond data center, the more durable forward drivers are the aerospace & defense up-cycle (orders +76% in Q1-2026, a genuinely high-moat annuity if it sustains), medical recovering off a destock, and the cross-sell program — all higher-quality than the ePOD bet but individually smaller.

Verdict: mixed-quality growth. The historical growth was acquired and is now ex-growth on an organic basis; the forward growth is a credible cyclical inflection plus a real-but-lumpy, low-moat secular bet. High-quality growth would show up as organic outgrowth at rising returns on capital; RRX has the inflection but not yet the returns.

6. Financial Quality

The five-year financial arc, in one table (figures from the 10-Ks; the discontinuity in 2021–2023 is the Rexnord PMC and Altra deals layering in, then the 2024 WEG divestiture stepping revenue back down):

The shape tells the story: revenue and margin step up with each deal, leverage spikes to 5.7x on the 2023 Altra close, and the subsequent three years are a deleveraging-plus-margin grind — with ROIC falling, not rising, through it. (Fact: 10-K filings.)

Margins are the genuine good-news story. Gross margin rose from ~33% (2023) to ~37.4% (2025) and management describes it as top-quartile; adjusted EBITDA margin reached ~22% in 2025 and is guided to ~22.2% in 2026. This is real operating improvement driven by synergy capture, footprint rationalization, and price/cost discipline — and it is the single most defensible plank of the bull case, because unlike the volume line it is largely within management’s control.

But the headline cash and earnings figures need three large adjustments.

1. GAAP vs. adjusted EPS — a ~$5.40 wedge. FY2025 GAAP diluted EPS was $4.20; adjusted diluted EPS was ~$9.6 (the 10–11x guide midpoint implies this; the proxy’s incentive-plan “Adjusted EPS” metric of $10.00 uses a different, more generous definition). The dominant bridge item is ~$346M/year of acquired-intangible amortization — roughly $4/share after tax — a non-cash, deal-related charge that is defensible to add back but that will recur into the late 2030s (Altra customer relationships amortize through ~2037). A second, more aggressive add-back is ~$37M of stock-based compensation, a real recurring economic cost. The honest “owner-earnings” figure sits between GAAP and adjusted — call it ~$8–9/share once SBC is treated as the cost it is.

2. Free cash flow is overstated by a one-time financing maneuver. Reported FY2025 operating cash flow of $990.8M and FCF of ~$893M were inflated by a new $400M accounts-receivable securitization launched 30 June 2025, under which $372.5M of receivables were sold and derecognized at year-end — essentially the entire +$345M “receivables” cash inflow and the reason trade receivables fell from $843M to $524M. The 10-K explicitly attributes the OCF increase “primarily” to this sale. Sustainable FCF is therefore closer to ~$520M, consistent with the company’s own 2026 FCF guide of $650M (which assumes working-capital investment to support growth). This also means the 106.5% FCF-conversion that helped drive 2025 bonus payouts was flattered by a balance-sheet maneuver.

3. Returns on capital are poor and have not improved. ROIC is ~4.6% (and was ~6.6% before the Altra deal) — below an ~8–9% WACC. ROE of ~13% is flattered by deeply negative tangible equity: $6.61B goodwill + $3.42B intangibles ≈ $10.0B against $6.85B of total equity, so tangible book value is roughly negative $48/share. Interest expense of $349M consumes roughly half of operating income — the visible cost of having funded Altra at 6.05–6.40% rates in 2023. Capex is genuinely low (~$98M, 1.6% of sales), which is the one structural support for cash conversion.

Quality-of-earnings flags (detailed in Section 8): the 2023 GAAP net loss was deal/disposal noise (impairments, integration costs, interest), not an operating collapse; the 2024 WEG divestiture was realized at a loss, not a gain; and two of five goodwill reporting units carry <10% headroom in the annual impairment test — non-trivial impairment risk given $6.6B of goodwill earning sub-WACC returns.

Verdict: economics are improving but have not yet earned the cost of capital. Margins and conversion are real; reported FCF and EPS both flatter the underlying picture; ROIC below WACC is the single most important financial fact about this company and the reason the cohort-cheap EV/EBITDA multiple is earned, not anomalous.

7. Capital Allocation

RRX’s capital-allocation story over the last five years is, in essence, one giant levered acquisition followed by a disciplined cleanup. The verdict is mixed-leaning-negative on the deals themselves and constructive on what management has done since.

The M&A scorecard:

The deals (the crux).

• Rexnord PMC (Nov-2021, ~$4.0B, tax-free Reverse Morris Trust). Scale in mechanical power transmission; ~$120M of targeted run-rate synergies. Qualitatively integrated; no audited synergy scorecard in the filings.
• Altra Industrial Motion (closed Mar-2023, $5,134.6M total — $62.00/share for the equity plus assumed debt). ~$4.76B of the $5.13B price (93%) was goodwill + intangibles ($2,614.6M goodwill; $2,142.0M intangibles, principally $1,710M of 14-year customer relationships). Funded with $4,700M of 6.05–6.40% senior notes plus a term loan. Targeted ~$160M of run-rate cost synergies plus cross-sell. This is the value-destruction question made concrete: ROIC fell from ~6.6% pre-deal to ~4.6%, and the equity has worked despite the deal — on deleveraging and re-rating — not because of it.
• Arrowhead (Nov-2021, $315.6M) — food & beverage conveying, folded into AMC.
• Industrial Motors & Generators divested to WEG (closed Apr-2024, $444M) — sold at a loss ($57.3M goodwill impairment + $87.7M held-for-sale loss booked in 2023, plus $8.5M at close), a clean disposal of a low-margin commodity business that improved the portfolio’s mix even though it was realized below carrying value.

Since the deals — disciplined repair. Gross debt has fallen from ~$6.4B (2023) to ~$4.79B (2025); net debt from ~$5.8B to ~$4.27B; net-debt/EBITDA from ~5.7x to ~3.6x (≈3.0x on adjusted EBITDA). Free cash flow now goes almost entirely to debt paydown (~$669M repaid in 2025) and the dividend (~$93M); buybacks are effectively suspended ($0 in 2025; $50M in 2024; $145M remains on a 2021 authorization) and there has been no new M&A. The dividend ($1.40/share, ~33% of GAAP EPS) has been roughly frozen at $0.35/quarter for two years to prioritize deleveraging — a sensible, if unexciting, posture. Capex discipline is consistent (~1.6% of sales). Share count is essentially flat (~66.4M).

Incentives are now better-aligned — but the timing is telling. The 2025 long-term plan (60% PSUs / 40% RSUs) uses three equally-weighted PSU metrics — relative TSR, ROIC, and Altra synergy achievement — plus a revenue-growth multiplier. Crucially, ROIC is back in the plan, and adjusted EPS is 50% of the annual bonus (with adjusted FCF conversion at 30%). But ROIC was dropped from the 2023 and 2024 PSUs “given the challenges associated with calculating ROIC stemming from the Rexnord PMC merger and Altra acquisition” and re-added only for 2025 — i.e., executives were not held to a capital-returns standard during the very period the capital was deployed. The objective scoreboard is sobering: the 2023 rTSR-only PSUs paid 0%, with RRX’s three-year relative TSR ranking at the 17th percentile of the S&P 900 Industrials. CEO total comp was ~$11.5M (2025), ~88% at risk.

Verdict: management overpaid for Altra (returns below WACC, value not yet created) but has executed the post-deal repair credibly — deleveraging, margin capture, portfolio cleanup, and a tightened, ROIC-inclusive incentive plan. The forward risk is that a new CEO with a growth mandate re-levers the balance sheet for another large deal before the last one has earned its keep.

8. Changes and Headwinds — Last Two Years

CEO succession (the biggest change). On 22 April 2026 RRX announced that Aamir Paul — President of North America and an Executive Committee member at Schneider Electric, where he ran a ~$17B business with deep data-center and discrete-automation exposure — will succeed Louis Pinkham as the company’s sixth CEO, effective no later than 1 July 2026. Pinkham led the seven-year transformation (Rexnord, Altra, the WEG divestiture, the margin program). The hire is logically consistent with the data-center/automation pivot, but it injects real execution and strategy risk at a pivotal moment, and it raises the specific question of whether the new CEO’s instincts run toward another large, levered deal.

Portfolio and balance-sheet actions. The 2024 WEG divestiture completed the portfolio sharpening; the 2025 refinancing (a new $850M term loan and a $1,500M undrawn revolver, November 2025) termed-out the 2026 note maturity and preserved liquidity; the June-2025 AR securitization (Section 6) is both a liquidity tool and a cash-flow-optics flag.

Tariffs. Management estimates an unmitigated annual tariff impact of ~$127M (reduced from ~$155M after the IEEPA-to-Section-232/122 shifts), expects to be dollar-cost-neutral by mid-2026 and margin-neutral by year-end via price and sourcing, and — interestingly — sees a share-gain opportunity in PES because its high US-steel-content, in-region-manufactured motors help OEM customers qualify finished goods for lower tariff rates. Net, tariffs are a manageable but real near-term margin headwind that the company is actively mitigating.

Operating headwinds. Rare-earth-magnet supply constraints (~30bps drag in AMC in Q1-2026), residential-HVAC weakness (down ~20% but stabilizing), and an OEM-heavy mix that pressures margin in the near term (OEM carries 10–20 points lower margin than aftermarket, though it builds the installed base that drives future aftermarket pull).

Verdict: net neutral-to-modestly-positive on the thesis. The cycle is inflecting and tariffs are being managed, but the CEO transition and the persistent margin-mix pressure are genuine offsets, and none of these changes has yet moved the needle on the core problem — returns below the cost of capital.

9. Risk Analysis

The dominant risks cluster on the same fault line: a full-priced equity on a business that has not yet demonstrated it can earn its cost of capital, with the catalysts that would prove it (cycle, synergies, DC ramp) all still in front of it and at least one (DC) structurally suspect. There is no catastrophic-loss risk — this is a cash-generative, investment-grade-ish industrial — but the path to a permanent capital impairment runs through a stalled recovery plus a re-levering deal.

10. Valuation Discussion (Embedded Expectations)

At ~$219.75 (66.39M shares → ~$14.6B market cap; +$4.27B net debt → ~$18.9B enterprise value), RRX trades at:

• ~15.9x GAAP EBITDA (~$1.19B) and ~14.4x adjusted EBITDA (~$1.31B);
• ~20.7x forward adjusted EPS (FY2026 guide midpoint ~$10.60) and ~23x trailing adjusted EPS (~$9.6); the GAAP P/E of ~51x is meaningless given the amortization distortion;
• ~36x sustainable FCF (~$520M) / ~21x reported FCF (~$893M); ~29x the company’s own $650M 2026 FCF guide.

Peer comparison (approximate; peer figures from public filings and market data; reconcile before quoting). The table makes the “cheap-but-earned” point concrete — RRX screens cheapest in the group on EV/EBITDA precisely because it pairs the lowest ROIC with the highest leverage:

The cleanest read is that RRX trades roughly where Roper and Timken do on EV/EBITDA — well below the AME/ETN/PH/ROK/NVT compounder cluster — but with returns on capital at the bottom of the entire group. The discount is rational. (Source: public filings; market data.)

The two-sided valuation tension. Cross-sectionally, RRX is among the cheapest names in the diversified-industrial cohort on EV/EBITDA. But against its own history it is at the 97th percentile — its richest valuation ever — after a +51% year. Both statements are true, and reconciling them is the whole exercise: the peer discount is earned (lowest ROIC, highest leverage, lowest-quality blended growth), so the bull case cannot rest on the gap closing toward AME/ETN/PH. It must rest on RRX’s own fundamentals improving enough to justify a multiple it has never sustained.

Embedded expectations. At ~14.4x adjusted EBITDA and ~20.7x forward EPS, the market is underwriting that (i) the cyclical recovery is durable and broad (not a one-quarter head-fake), (ii) the data-center ramp to ~$900M of 2027 revenue largely materializes, (iii) AMC mix-shift and continued synergy capture lift consolidated returns toward — and eventually through — the cost of capital, and (iv) deleveraging continues toward ~2.5x. That is a coherent bull stack, but it is a stack — every layer has to hold — and the price gives back little if any of it for free. The factor tape reinforces the caution: this is a high-beta (~1.5) cyclical with a poor long-run Sharpe (~0.25) and a >50% historical max drawdown, enjoying a sharp recent re-rating, not a low-vol compounder that has earned a premium multiple.

Scenario analysis (illustrative; not a price target):

• Bear (~$120–145): Recovery stalls, organic returns to flat, DC ramp slips or competes away, multiple de-rates toward its own historical mid-point (~10–11x EV/EBITDA on ~$1.25–1.3B EBITDA). This roughly reclaims the December-2025 level.
• Base (~$160–185): Cycle inflects modestly, synergies + DC lift adjusted EPS to ~$10.5–11.5 and adjusted EBITDA toward ~$1.4B, ROIC creeps toward ~6–7%, multiple settles at ~12x EV/EBITDA / ~15–16x EPS — a fair multiple for a deleveraging, sub-WACC-but-improving cyclical.
• Bull (~$230–270+): Broad recovery, DC hits ~$900M in 2027, AMC margins reach the mid-20s, ROIC clears WACC, and the market sustains the current ~14x EV/EBITDA / ~21x EPS on ~$11.5–12.5 adjusted EPS — the case the price largely already embeds.

The asymmetry skews unfavorably at this price: the base case is roughly flat-to-down from spot, the bull case is what is already priced, and the bear case is a meaningful drawdown. No price target, no recommendation — this is an embedded-expectations read.

11. Variant Perception

Consensus has converged on a constructive view: RRX is a successful transformation story — a deleveraging self-help name with a credible data-center/automation growth vector and an inflecting industrial cycle — and the stock’s +51% year reflects the market rewarding that turn. Sell-side framing leans on the cohort-cheap EV/EBITDA and the “ROIC re-added to incentives, synergies ahead of plan” governance improvements.

The strongest bull case: The deleveraging is structurally bullish for the equity (every turn of debt repaid transfers enterprise value to equity holders), the cycle is genuinely inflecting (orders +8.5%, AMC +34%), the data-center ramp is large and partly contracted ($735M order, ~$900M 2027 guide), synergies are running ahead of plan, and the stock is the cheapest in its group on EV/EBITDA — so a re-rating toward peer multiples plus EPS growth could compound attractively. A capable, data-center-native new CEO could accelerate the growth pivot.

The strongest bear case: RRX has never earned its cost of capital since the Altra deal (ROIC ~4.6% < WACC), and the equity has worked on financial engineering and re-rating rather than economic value creation. The cohort-cheap multiple is a value trap in Marathon terms — a cheap multiple attached to the lowest-return, most-levered name, whose headline growth vector sits in the least-defended pocket of the industry. Organic growth is barely positive, reported FCF is inflated by a one-time securitization, insiders have bought nothing, the relative-TSR scoreboard reads 17th percentile, and the stock is at its richest-ever valuation just as a brand-new CEO inherits a half-finished integration.

The 3–5 assumptions that matter most:

1. Does consolidated ROIC climb through ~8% WACC within ~2–3 years? (The whole quality debate.)
2. Is the data-center ePOD ramp ($120M→~$900M) durable, or does it mean-revert on competitive capacity?
3. Is the Q1-2026 industrial inflection real and broad, or a destocking-rebound head-fake?
4. Does the new CEO keep deleveraging, or re-lever for another large deal?
5. Is sustainable FCF ~$520M or ~$893M? (Determines the true FCF yield.)

Falsification. The bull case breaks if two consecutive quarters show organic growth fading back toward flat with ROIC stuck at ~5%; the bear case breaks if two consecutive quarters show ROIC climbing toward 7–8% on broad organic outgrowth and the DC backlog converting on schedule. The factor-positioning read — a high-beta cyclical surge on a long-run-mediocre name, not a quality-compounder profile — argues consensus may be extrapolating a cyclical/financial recovery into a structural-quality re-rating it has not earned.

12. Fact vs. Interpretation

13. Open Questions

1. What is the actual aftermarket/recurring-revenue mix by segment? Without it, the “6x aftermarket pull” moat claim cannot be verified.
2. What is segment-level adjusted EBITDA and segment ROIC? The 10-K discloses only GAAP segment operating income; the returns case hinges on AMC/IPS economics that are not fully disclosed.
3. Will the AR securitization be maintained, expanded, or unwound — and what is the steady-state FCF once working capital normalizes for growth?
4. What are the precise leverage covenants on the revolver/term loan, and how much downturn cushion exists at ~3.6x?
5. What is the new CEO’s capital-allocation philosophy — continued deleveraging and buybacks, or another transformational deal?
6. Beyond the $735M order, what is the contracted vs. pipeline split of the ~$900M 2027 data-center number, and what are 2028 commitments?
7. When does ROIC realistically cross WACC under the base case, and what organic growth + margin combination does that require?

14. What Must Be True

Bull case — what must be true: The industrial cycle inflection of Q1-2026 is real and broadens through 2026–2027; AMC delivers high-single-digit organic growth with margins recovering toward the mid-20s as rare-earth/tariff headwinds clear; the data-center ramp converts toward ~$900M of 2027 revenue; Altra synergies and cross-sell continue to flow; deleveraging reaches ~2.5x, freeing capacity for buybacks; and — the linchpin — consolidated ROIC climbs through the ~8% cost of capital within two to three years. Falsification test: two consecutive quarters of organic growth fading toward flat while ROIC remains stuck near ~5% would break the bull thesis and expose the richest-ever multiple.

Bear case — what must be true: The Q1-2026 inflection is a destocking-rebound head-fake; the data-center ePOD vector mean-reverts as Eaton/Vertiv/nVent flood capacity; organic growth returns to flat; ROIC never clears WACC; reported FCF normalizes lower as the securitization benefit washes out; and the new CEO re-levers for another value-dilutive deal — leaving the cohort-cheap multiple to be revealed as a value trap and the stock to de-rate from its 97th-percentile valuation. Falsification test: two consecutive quarters of ROIC climbing toward 7–8% on broad-based organic outgrowth, with the data-center backlog converting on schedule, would break the bear thesis.

15. Source Appendix

See the Source Appendix (Appendix B) for the full, dated source list. Primary sources: Regal Rexnord FY2021–FY2025 Forms 10-K (SEC CIK 0000082811; FY2025 filed 2026-02-20); the FY2023 10-K Note 4 (Altra purchase accounting); the Q4-2025 earnings release 8-K (filed 2026-02-05) and the Q1-2026 earnings call transcript (7 May 2026); the CEO-succession 8-K (filed 2026-04-22); the 2026 proxy statement (DEF 14A, filed 2026-03-18); and the Form 3/4/5 insider corpus (2021–2026). Quantitative cross-checks drew on public market data for price history and valuation and on a public factor model for factor loadings and risk statistics; peer context came from the public filings of close comparables (nVent, Ametek, Eaton, Emerson, Rockwell, Parker-Hannifin, Roper, A.O. Smith). All management commentary is treated as hypothesis and validated against filings and external data.

APPENDIX A — Standard Diligence Questionnaire

Regal Rexnord Corporation (NYSE: RRX) — as of 2026-06-28

Supplemental to the main analysis. Fact / Interpretation / Assumption labeled where it matters.

General

What thoughtful questions have other investors asked about this company? The recurring institutional questions (visible in the Q1-2026 call) are: (1) where is the conservatism in 2026 guidance, given order rates suggest upside (Fact — Baird, Goldman, Barclays all probed this); (2) the durability and cadence of the data-center/ePOD ramp (the $900M-2027 number); (3) AMC margins, which have declined year-on-year for ~11 consecutive quarters (Barclays flagged this directly) — is the back-half recovery real; (4) the OEM-vs-aftermarket mix headwind; and (5) implicitly, whether ROIC will ever clear the cost of capital after the Altra deal. The most thoughtful bear question is the one the sell-side under-asks: why pay a record multiple for a sub-WACC-returns business?

Cyclicality & Earnings Nature

Are earnings at a cyclical high or low? Closer to a cyclical low inflecting up (Interpretation). Revenue declined 2023→2025 on destocking; organic was +0.8% in FY2025 and +1.6% in Q1-2026, with residential HVAC down ~20% but stabilizing and general industrial just turning. Margins, however, are near a structural high (top-quartile gross margin) on synergy capture — so the unusual setup is depressed volumes on elevated margins.

Driven by external environment or internal actions? Both: margins are internal (synergies, footprint, price/cost); volumes are external (cycle). The recent EPS recovery off the 2023 trough is partly the absence of one-time deal/impairment charges (internal/accounting) and partly cycle.

How stable are revenues? Moderately cyclical. ~97% of the legacy components book is replacement-driven over a cycle, but the OEM/short-cycle and residential-HVAC exposure makes quarterly revenue swing with the industrial cycle; data center adds lumpy project revenue.

Outlook for products/services; how big is the market? Core motors/PT ~$220B growing low-single-digit; discrete automation ~$200B mid-single-digit; data-center power growing 20%+. Mix of growing (AMC, data center, aerospace) and mature/cyclical (PES motors). Mostly domestic revenue (~70% NA) but global manufacturing.

Business Quality & Competitive Moat

Is the industry getting more or less competitive? Data-center power is getting more competitive (a capital-flooded land-grab); core PT is stable-to-consolidating; commodity motors remain intensely competitive. (Interpretation.)

How profitable is the business (ROIC, ROE)? Poorly, by the honest measure: ROIC ~4.6% (below ~8–9% WACC); ROE ~13% but flattered by deeply negative tangible equity. Adjusted EBITDA margin ~22% is genuinely good; the disconnect between strong margins and weak ROIC is the price paid for the acquisitions.

How profitable is the industry; barriers to entry? Average. PT components have real spec-in/MRO barriers (narrow moat); motors and DC-assembly have low barriers; automation controls (which RRX does not own) have high barriers.

Can the business be easily understood? Yes at the segment level; the complication is the M&A accounting (goodwill, intangible amortization, deal charges) that drives a ~$5.40 wedge between GAAP and adjusted EPS.

Undermined by foreign low-cost labor? Partially in commodity motors (PES) — Asian competition is real. PT components and aerospace/medical motion are more defended. RRX itself manufactures heavily in Mexico/China/India.

Do brands matter? Nature of competition? Switching costs? Brands matter modestly (Rexnord, Altra, Marathon-era PT names carry distributor/engineer recognition); competition is on engineering spec, price, lead-time, and aftermarket service; switching costs are real in spec’d-in PT components and certified aerospace/medical motion, low elsewhere.

Financial Condition & Balance Sheet

Assets not fully on the balance sheet? The aftermarket installed-base “annuity” and distributor relationships are off-balance-sheet intangible value the company emphasizes but does not quantify. Conversely, ~$10.0B of recognized goodwill+intangibles arguably overstate economic asset value given sub-WACC returns.

Off-balance-sheet liabilities? The $400M AR securitization derecognizes ~$372.5M of receivables (a financing in economic substance); operating leases; pension (~$106M). Nothing alarming, but the securitization materially flatters reported cash flow.

How conservative is the accounting? Mixed. Amortization add-back to adjusted EPS is standard; SBC add-back is aggressive; the securitization-driven FCF is the clearest QoE flag. Two of five goodwill units carry <10% impairment headroom.

How CapEx-hungry? Not hungry — capex ~1.6% of sales (~$98M). This is the structural support for cash conversion.

Capital Allocation & Management

How much FCF; how is it used; philosophy? Sustainable FCF ~$520M (reported ~$893M inflated by securitization). Used almost entirely for debt paydown (~$669M in 2025) plus the dividend (~$93M). Philosophy is explicitly deleveraging-first post-Altra.

Significant acquisitions recently? Rexnord PMC (2021, ~$4.0B), Altra (2023, ~$5.1B), Arrowhead (2021, $316M); divested Industrial Motors to WEG (2024, $444M, at a loss). No M&A since — the open question is whether the new CEO resumes it.

Buying back shares? Issuing to insiders? Buybacks effectively suspended ($0 in 2025; $145M authorization remains). No large issuance; only minor SBC dilution; share count flat ~66.4M.

Compensation / motivations of management? CEO comp ~$11.5M, ~88% at risk. Annual bonus: adjusted EPS 50% / adjusted FCF conversion 30% / revenue-growth initiatives 20%. LTI (60% PSU): relative TSR, ROIC, and Altra-synergy achievement, equally weighted. ROIC was re-added only in 2025 after being dropped in 2023–24 — so executives were not held to a capital-returns standard while the capital was deployed. The 2023 rTSR PSUs paid 0% (17th percentile). New CEO Aamir Paul (ex-Schneider) effective ~July 1, 2026.

Valuation & Market Data

ADR, MLP, or K-1 issuer? No — a US C-corporation; standard 1099 dividend; not an ADR/MLP.

Dividend policy? $1.40/share annual (~$0.35/quarter), roughly frozen for two years to prioritize deleveraging; ~33% of GAAP EPS payout. Long payment history (legacy Regal Beloit), modest yield (~0.6% at current price).

How profitable; is net income diverging from cash from operations? Net income (GAAP) is depressed by amortization/interest; CFO diverges above net income (non-cash amortization) but FY2025 CFO is additionally inflated by the one-time securitization. Normalize both before drawing conclusions.

Risks & Downside

What would cause the stock to decline? A stalled industrial recovery, a data-center disappointment/mean-reversion, a value-dilutive re-levering deal, a goodwill impairment, or simple multiple de-rating from a record-high valuation. (See Section 9 risk matrix.)

Risk of catastrophic loss / total loss? Low. This is a cash-generative, ~3.6x-levered, investment-grade-ish industrial with diversified end-markets; a total loss would require a severe, prolonged downturn compounded by a re-levering misstep. The realistic downside is a meaningful drawdown (bear case ~$120–145), not a wipeout.

Recent News & Events

Has the business environment changed recently? Yes: an inflecting industrial cycle (orders +8.5%), accelerating data-center/AMC demand, tariff turbulence (~$127M unmitigated, being managed), rare-earth-magnet constraints, and — most importantly — a CEO succession (Pinkham → Aamir Paul, ~July 1, 2026).

Significant acquisitions / accounting changes / new markets? No new M&A; the June-2025 AR securitization and November-2025 refinancing are the notable balance-sheet changes; new Texas and Canada plants for the data-center ramp are coming online by mid-2026.

(Note: the recent-events read is built from the company’s filings, the Q1-2026 transcript, and the 8-K calendar.)

APPENDIX B — Source Appendix

Regal Rexnord Corporation (NYSE: RRX) — Research as of 2026-06-28

All non-obvious facts in the memo trace to the sources below. Primary (filings) over secondary; recent over stale. Management commentary is treated as hypothesis and validated against filings and external data.

Primary — SEC filings (EDGAR, CIK 0000082811)

Quantitative cross-checks (third-party; reconciled to filings)

• Company financial statements & ratios — multi-year income statement, balance sheet, cash flow, and derived ratios (ROIC ~4.6%, ROE ~13%, net debt/EBITDA ~3.6x), enterprise value, valuation multiples, and per-share data, reconciled to the filings.
• Public market price data — five-year split/dividend-adjusted price history (price action, 50/200-day EMAs, beta) and own-history valuation percentiles (composite 97.3rd, P/E 97.5th, P/B 95.0th, P/S 99.2nd, as of 2026-06-26).
• Public factor model — factor loadings (Market beta ~1.25–1.49; Industrials/Automation cyclical basket; ~zero Momentum-factor loading; low Quality), leaderboard (y1 +50.9%/Sharpe 1.03; lifetime +10.4%/Sharpe 0.24; max DD −53.6%; de-annualized m6 ~+52%), beta/alpha/relative strength, idiosyncratic vol ~34%, related stocks (ST, DOV, NPO, IR, EMR, RBC, PH, TKR).

Peer / industry context

Peer comps and industry framing drew on the public filings and market data of close comparables: nVent (NVT), Ametek (AME), Eaton (ETN), Emerson (EMR), Rockwell (ROK), Parker-Hannifin (PH), Roper (ROP), and A.O. Smith (AOS). Bearings/PT pure-play context (Timken, RBC Bearings, SKF), motor competitors (Nidec, WEG, Broad-Ocean, EBM-Papst), and data-center power incumbents (Eaton, Vertiv, Schneider, ABB, Legrand) reflect publicly available industry information, flagged as Interpretation where not directly sourced.

Analytical frameworks

Greenwald & Kahn, Competition Demystified (moat taxonomy, ROIC/market-share tests) and Chancellor/Marathon, Capital Returns (supply-side capital-cycle analysis).